The Cannaisseur Group, Inc.

TCRG ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2026 FY2025 FY2024 FY2023 FY2022
Revenue $0 $700 $53.1K $88.1K
Cost of Revenue $910 $4.3K $27.0K $42.8K
Gross Profit $-910 $-3.6K $26.2K $45.3K
Gross Margin -510.7% 49.2% 51.4%
Operating Expenses
Research & Development
SG&A Expense $1.7M $1.3M $216.1K $137.2K
Operating Income $-1.7M $-1.3M $-189.9K $-91.9K
Operating Margin -180,939.9% -357.4% -104.3%
Interest Expense $1.7K $2.1K
Pretax Income $-1.8M $-1.3M $-172.6K $-94.0K
Income Tax Expense $0 $0 $0 $0
Net Income $-1.8M $-1.3M $-128.0K $-80.1K
Net Margin -181,348.3% -241.0% -90.9%
EPS (Basic) $-0.03 $-0.03 $0.00 $0.00
EPS (Diluted) $-0.03 $-0.03 $0.00 $0.00
Shares Outstanding (Basic) 60.5M 53.9M 43.8M 39.7M 36.2M
Shares Outstanding (Diluted) 60.5M 53.9M 43.8M 39.7M 36.2M
Dividends Per Share